HIT Cell Therapy Wipes Out Solid Tumors in Mice Where Standard CAR T Cells Fall Short
Columbia researchers identified that all solid tumor cells in kidney, pancreatic, and ovarian cancers express at least trace amounts of CD70, and that HIT cells - more sensitive than standard CAR T - completely eliminated those tumors in mice. Human trials are planned.